Evaluation of supply sustainability of vaccine alternatives with multi-criteria decision-making methods

dc.authoridYAZICI, Emre/0000-0002-3661-2119
dc.authoridALAKAS, Haci Mehmet/0000-0002-9874-7588
dc.contributor.authorYazici, Emre
dc.contributor.authorUner, Sabire Irem
dc.contributor.authorDemir, Asli
dc.contributor.authorDinler, Sevda
dc.contributor.authorAlakas, Haci Mehmet
dc.date.accessioned2025-01-21T16:40:43Z
dc.date.available2025-01-21T16:40:43Z
dc.date.issued2022
dc.departmentKırıkkale Üniversitesi
dc.description.abstractBackground: The treatment of the COVID-19 epidemic, whose contagious features are changing day by day, is the most current problem today throughout of the world. In order to be protected from COVID-19 and reduce its spread, it is of great importance to follow the rules such as mask, distance and hygiene. In addition, one of the most important ways to prevent the epidemic is to develop population immunity. The most important tool in having population immunity is vaccination. Aims: During the COVID-19 pandemic, there have been problems in the supply process of many products in food and health sectors. Vaccine is also one of the most difficult tools to supply. In this context, the study focused on the selection of the vaccine provided by the countries within the scope of population vaccination studies. Materials & Methods: At the selection point, the criteria affecting the purchasing process were determined and the weights of these criteria were calculated using the AHP method. Then, the criteria weights obtained were used to rank the alternatives in an integrated manner in the Preference Ranking Organization Method for Enrichment of Evaluations (PROMETHEE) and Technique for Order Preference by Similarity to Ideal Solution (TOPSIS) methods. The results of both methods were analyzed comparatively. Results: According to the TOPSIS Method, the first alternative is Oxford-AstraZeneca for all countries, and BioNTech for all countries in the PROMETHEE method. Discussion: The vaccine storage conditions criterion is the most important in vaccine supply. The criterion with the lowest importance is Supply Cost. It has been revealed that cost elements remain in the background under pandemic conditions. Conclusion: Vaccine evaluation studies and policy recommendations are presented by considering public health in the selection of vaccine alternatives.
dc.description.sponsorshipHigher Education Institution in the 100/2000 PhD Scholarship program
dc.description.sponsorshipEmre Yazc is supported by the Higher Education Institution in the 100/2000 PhD Scholarship program under the title of Operations Research. None.
dc.identifier.doi10.1002/hpm.3481
dc.identifier.endpage2444
dc.identifier.issn0749-6753
dc.identifier.issn1099-1751
dc.identifier.issue4
dc.identifier.pmid35501891
dc.identifier.scopus2-s2.0-85129195883
dc.identifier.scopusqualityQ2
dc.identifier.startpage2421
dc.identifier.urihttps://doi.org/10.1002/hpm.3481
dc.identifier.urihttps://hdl.handle.net/20.500.12587/24754
dc.identifier.volume37
dc.identifier.wosWOS:000789679300001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofInternational Journal of Health Planning and Management
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_20241229
dc.subjectanalytic hierarchy process; COVID-19; multi-criteria decision making; PROMETHEE; vaccine selection
dc.titleEvaluation of supply sustainability of vaccine alternatives with multi-criteria decision-making methods
dc.typeArticle

Dosyalar